American Society of Clinical Oncology

Latest stories

11h
The Norwich Bulletin
Doctors urging use of HPV vaccineconsensus statement saying the HPV vaccine was "tragically underused" and calli
Doctors urging use of HPV vaccine
The Norwich Bulletin / Posted 11 hours ago
consensus statement saying the HPV vaccine was "tragically underused" and calling on doctors to strongly recommend it. The American Society of Clinical Oncology followed with a similar statement.Cancer doctors have been reaching out to primary-care... Read more
5d
Business Wire
Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firmstatements to investors and/or failed to disclose: that the Company’s abstract
Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm
Business Wire / Posted 5 days ago
statements to investors and/or failed to disclose: that the Company’s abstract for antibody-drug IMMU-132 submitted to the American Society of Clinical Oncology (ASCO) for presentation at their 2016 Annual Meeting contained previously disclosed... Read more
13 related stories
5d
Fortune
How Blood Testing Technology Got So Hotfirst-of-its-kind blood test to assess the efficacy of its lung cancer drug, Ta
How Blood Testing Technology Got So Hot
Fortune / Posted 5 days ago
first-of-its-kind blood test to assess the efficacy of its lung cancer drug, Tarceva, for different patients. And at June’s American Society of Clinical Oncology annual meeting, Guardant Health unveiled a trove of data showing that its blood-testing... Read more
6d
FOX News
Cancer drug prices highest in US, least affordable in India, Chinacountries, which did not take into account discounts or rebates to list prices,
Cancer drug prices highest in US, least affordable in India, China
FOX News / Posted 6 days ago
countries, which did not take into account discounts or rebates to list prices, was presented at the annual meeting of the American Society of Clinical Oncology in Chicago. The lowest drug prices were found in India and South Africa. But after... Read more
6d
Business Wire
New Research Involving Circulogene’s Liquid Biopsy Further Validates Test’s Cancer Mutation Detection Capabilitiesof a new tumor mass earlier than current, standard-of-care imaging methods. Add
New Research Involving Circulogene’s Liquid Biopsy Further Validates Test’s Cancer Mutation Detection Capabilities
Business Wire / Posted 6 days ago
of a new tumor mass earlier than current, standard-of-care imaging methods. Additionally, research presented at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting demonstrated that Circulogene’s propriety DNA enrichment... Read more
7d
The Lewistown Sentinel
Local physicians help develop guidelinesfor treating a wide range of diseases have become a frequently used tool for ev
Local physicians help develop guidelines
The Lewistown Sentinel / Posted 7 days ago
for treating a wide range of diseases have become a frequently used tool for every physician in daily medical practice. The American Society of Clinical Oncology recently published three clinical practice guidelines for pancreatic cancer in the... Read more
7d
FOX News
Scientists find possible PTSD relief in retooled muscle relaxantimproved participants’ PTSD symptoms among several mental health indices. The
Scientists find possible PTSD relief in retooled muscle relaxant
FOX News / Posted 7 days ago
improved participants’ PTSD symptoms among several mental health indices. The findings were announced this month at the American Society of Clinical Oncology (ASCO) annual conference, and could eventually lead doctors to unroll the first PTSD... Read more
8d
Business Wire
IMMUNOMEDICS, INC. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuitabstract for the antibody-drug, conjugate sacituzumab govitecan IMMU-132 (“IMMU
IMMUNOMEDICS, INC. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
Business Wire / Posted 8 days ago
abstract for the antibody-drug, conjugate sacituzumab govitecan IMMU-132 (“IMMU-132”), that Immunomedics submitted to the American Society of Clinical Oncology (“ASCO”) for presentation at the 2016 ASCO Annual Meeting, contained previously... Read more
8d
Business Wire
Lundin Law PC Announces Investigation Of Immunomedics Inc. And Advises Investors With Losses to Contact the Firmof the Securities Exchange Act of 1934. Specifically, the investigation will fo
Lundin Law PC Announces Investigation Of Immunomedics Inc. And Advises Investors With Losses to Contact the Firm
Business Wire / Posted 8 days ago
of the Securities Exchange Act of 1934. Specifically, the investigation will focus on a June 2, 2016, media report that the American Society of Clinical Oncology ("ASCO") had removed a scheduled presentation by Immunomedics regarding the Company's... Read more
2 related stories
8d
Market Watch
Biotech stocks are in for more election trouble on drug pricingpatented cancer drugs. Americans fork out $8,694 for the same drugs. That’s the
Biotech stocks are in for more election trouble on drug pricing
Market Watch / Posted 8 days ago
patented cancer drugs. Americans fork out $8,694 for the same drugs. That’s the conclusion of a study just presented at an American Society of Clinical Oncology meeting by Daniel Goldstein of the Rabin Medical Center in Israel. It’s the same with... Read more
8d
Hartford Courant
Doctors Urging Use Of HPV Vaccineconsensus statement saying the HPV vaccine was "tragically underused" and calli
Doctors Urging Use Of HPV Vaccine
Hartford Courant / Posted 8 days ago
consensus statement saying the HPV vaccine was "tragically underused" and calling on doctors to strongly recommend it. The American Society of Clinical Oncology followed with a similar statement. Cancer doctors have been reaching out to... Read more
8d
The Hill
Advances in cancer will only happen through true collaborationAfter some three decades attending the American Society of Clinical Oncology (A
Advances in cancer will only happen through true collaboration
The Hill / Posted 8 days ago
After some three decades attending the American Society of Clinical Oncology (ASCO) annual meeting — the world's largest gathering of cancer professionals — we've seen many positive advances in cancer research, treatment, prevention, awareness and... Read more
10d
CBC.ca
When hope returns: a new drug takes on a rare, aggressive skin cancersystem to fight disease. Findings from one trial for a drug called avelumab we
When hope returns: a new drug takes on a rare, aggressive skin cancer
CBC.ca / Posted 10 days ago
system to fight disease. Findings from one trial for a drug called avelumab were presented earlier this month at the American Society of Clinical Oncology (ASCO) meeting in Chicago, the country's largest annual oncology conference. The... Read more
11d
Business Wire
IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics Inc.include, but are not limited to, that: (i) IMMU’s abstract for its cancer-treat
IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics Inc.
Business Wire / Posted 11 days ago
include, but are not limited to, that: (i) IMMU’s abstract for its cancer-treatment drug IMMU-132 submitted to the American Society of Clinical Oncology (“ASCO”) for presentation at the 2016 ASCO Annual Meeting contained previously... Read more
3 related stories
11d
Business Wire
AmoyDx ROS1-Diagnosetest leistet wichtigen Beitrag zu klinischer Phase-II-Studie zu Crizotinib zur Behandlung von Lungenkrebsheute berichtet wurde. Die Ergebnisse der OxOnc-Studie wurden im Rahmen der die
AmoyDx ROS1-Diagnosetest leistet wichtigen Beitrag zu klinischer Phase-II-Studie zu Crizotinib zur Behandlung von Lungenkrebs
Business Wire / Posted 11 days ago
heute berichtet wurde. Die Ergebnisse der OxOnc-Studie wurden im Rahmen der diesjährigen Jahresversammlung der ASCO (2016 American Society of Clinical Oncology Annual Meeting) präsentiert. (http://oxonc.com/pdfs/OxOncRelease020713.pdf). Das... Read more
742 related stories
12d
express
Powerful skin cancer drugs could wipe out tumours in ONE FIFTH of patientsdrugs have also shown a promising effect on other cancers, including advanced l
Powerful skin cancer drugs could wipe out tumours in ONE FIFTH of patients
express / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47 per cent... Read more
24 related stories
12d
Irish Examiner
A combination of new life-extending drugs for skin cancer have been approvedThe drugs have also shown a promising effect on other cancers, including advanc
A combination of new life-extending drugs for skin cancer have been approved
Irish Examiner / Posted 12 days ago
The drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Hampshire Chronicle
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Hampshire Chronicle / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Northern Echo
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Northern Echo / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
West Moreland Gazette
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
West Moreland Gazette / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Kingston Guardian
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Kingston Guardian / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Oxford Mail
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Oxford Mail / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Harrow Times
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Harrow Times / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Gazette News
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Gazette News / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Bolton News
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Bolton News / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Wandsworth Guardian
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Wandsworth Guardian / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
St Albans & Harpenden Review
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
St Albans & Harpenden Review / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Croydon Guardian
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Croydon Guardian / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
This is Oxfordshire
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
This is Oxfordshire / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Lancashire Telegraph
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Lancashire Telegraph / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Streatham Guardian
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Streatham Guardian / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Bury Times
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Bury Times / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
Gazette
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
Gazette / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
guardian-series
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
guardian-series / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
This is West Country
New life-extending drugs for skin cancer approveddrugs have also shown a promising effect on other cancers, including advanced l
New life-extending drugs for skin cancer approved
This is West Country / Posted 12 days ago
drugs have also shown a promising effect on other cancers, including advanced lung cancer. Research presented at the American Society of Clinical Oncology (Asco) conference last week showed that of 38 patients given the drugs, 47% responded,... Read more
24 related stories
12d
CBS News
Skin cancer could be hiding where you'd never expectthe body and melanoma, but it is linked to squamous cell skin cancer," said Sch
Skin cancer could be hiding where you'd never expect
CBS News / Posted 12 days ago
the body and melanoma, but it is linked to squamous cell skin cancer," said Schuchter, who also serves as an expert for the American Society of Clinical Oncology. Lichtenfeld concurred. "The authors have provided us with useful and... Read more
12d
Newsmax
Skin Cancer Check? Don't Forget Your Solesthe body and melanoma, but it is linked to squamous cell skin cancer," said Sch
Skin Cancer Check? Don't Forget Your Soles
Newsmax / Posted 12 days ago
the body and melanoma, but it is linked to squamous cell skin cancer," said Schuchter, who also serves as an expert for the American Society of Clinical Oncology. Lichtenfeld concurred. "The authors have provided us with useful and... Read more
13d
Business Wire
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Investigation of Immunomedics Inc. and Advises Investors with Losses to Contact the Firmof the Securities Exchange Act of 1934. Specifically, the investigation will fo
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Investigation of Immunomedics Inc. and Advises Investors with Losses to Contact the Firm
Business Wire / Posted 13 days ago
of the Securities Exchange Act of 1934. Specifically, the investigation will focus on a June 2, 2016, media report that the American Society of Clinical Oncology ("ASCO") had removed a scheduled presentation by Immunomedics regarding the Company's... Read more
3 related stories
14d
CNBC
Brexit panic makes this stock a buygroup of stocks on Cramer's radar on Tuesday were the biotech and pharma stocks
Brexit panic makes this stock a buy
CNBC / Posted 14 days ago
group of stocks on Cramer's radar on Tuesday were the biotech and pharma stocks, which could see traction from the American Society of Clinical Oncology (ASCO) conference. "Now that the Democratic primary has ended, I think we are going to... Read more
15d
The Columbian
Seattle doctor’s research is saving kids with rare cancerof Washington, was scheduled to present the results of the clinical trial Sunda
Seattle doctor’s research is saving kids with rare cancer
The Columbian / Posted 15 days ago
of Washington, was scheduled to present the results of the clinical trial Sunday in Chicago at the annual meeting of the American Society of Clinical Oncology. The work is one of five abstracts selected from more than 5,000 and deemed to have... Read more
16d
News-Medical-Net
Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomesBy Shreeya Nanda Research presented at the American Society of Clinical Oncolo
Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes
News-Medical-Net / Posted 16 days ago
By Shreeya Nanda Research presented at the American Society of Clinical Oncology annual conference suggests that consolidation therapy with tandem compared with single myeloablative autologous stem cell transplant (ASCT) can improve outcomes in... Read more
18d
Eye Witness News
Regulator says too many drugmakers chasing same cancer strategywould we be better off spending those resources into looking at more novel drug
Regulator says too many drugmakers chasing same cancer strategy
Eye Witness News / Posted 18 days ago
would we be better off spending those resources into looking at more novel drugs?” Pazdur told Reuters during the annual American Society of Clinical Oncology (ASCO) meeting in Chicago this week. Pazdur acknowledged that the success of a few... Read more
11 related stories
18d
Memphis Commercial Appeal
Experimental lab-produced antibody shrinks neuroblastoma, St. Jude researchers say— in 80 percent of newly diagnosed high-risk patients. Findings from the study
Experimental lab-produced antibody shrinks neuroblastoma, St. Jude researchers say
Memphis Commercial Appeal / Posted 18 days ago
— in 80 percent of newly diagnosed high-risk patients. Findings from the study were presented last week at the American Society of Clinical Oncology annual meeting in Chicago. The treatment being tested in the trial employs a mix of... Read more
18d
Newsmax
Too Many Drug Companies Chasing Same Cancer Strategy: FDAwould we be better off spending those resources into looking at more novel drug
Too Many Drug Companies Chasing Same Cancer Strategy: FDA
Newsmax / Posted 18 days ago
would we be better off spending those resources into looking at more novel drugs?" Pazdur told Reuters during the annual American Society of Clinical Oncology (ASCO) meeting in Chicago this week. Pazdur acknowledged that the success of a few... Read more
11 related stories
18d
FOX News
US regulator says too many drugmakers chasing same cancer strategywould we be better off spending those resources into looking at more novel drug
US regulator says too many drugmakers chasing same cancer strategy
FOX News / Posted 18 days ago
would we be better off spending those resources into looking at more novel drugs?" Pazdur told Reuters during the annual American Society of Clinical Oncology (ASCO) meeting in Chicago this week. More on this... Pazdur acknowledged that the... Read more
11 related stories
18d
Channel NewsAsia
Regulator says too many drugmakers chasing same cancer strategywould we be better off spending those resources into looking at more novel drug
Regulator says too many drugmakers chasing same cancer strategy
Channel NewsAsia / Posted 18 days ago
would we be better off spending those resources into looking at more novel drugs?" Pazdur told Reuters during the annual American Society of Clinical Oncology (ASCO) meeting in Chicago this week. Pazdur acknowledged that the success of a few... Read more
11 related stories
18d
The Globe and Mail
Friday's analyst upgrades and downgradesday failed to alleviate his concerns. “AbbVie is gradually diversifying from H
Friday's analyst upgrades and downgrades
The Globe and Mail / Posted 18 days ago
day failed to alleviate his concerns. “AbbVie is gradually diversifying from Humira; however, some of the ASCO [American Society of Clinical Oncology] updates after the R&D day, along with ongoing positive updates from Lilly's immunology... Read more
4 related stories
18d
Reuters
Regulator says too many drugmakers chasing same cancer strategywould we be better off spending those resources into looking at more novel drug
Regulator says too many drugmakers chasing same cancer strategy
Reuters / Posted 18 days ago
would we be better off spending those resources into looking at more novel drugs?" Pazdur told Reuters during the annual American Society of Clinical Oncology (ASCO) meeting in Chicago this week. Pazdur acknowledged that the success of a few... Read more
11 related stories
18d
NBC News
Too Many 'Me-Too' Cancer Drugs? FDA Official Askstherapies, designed to disable the PD-1 protein that tumors use to evade the im
Too Many 'Me-Too' Cancer Drugs? FDA Official Asks
NBC News / Posted 18 days ago
therapies, designed to disable the PD-1 protein that tumors use to evade the immune system, were the stars of the annual American Society of Clinical Oncology (ASCO) meeting in Chicago this week. The Food and Drug Administration has approved... Read more
11 related stories
18d
Channel NewsAsia
US regulator says too many drugmakers chasing same cancer strategywould we be better off spending those resources into looking at more novel drug
US regulator says too many drugmakers chasing same cancer strategy
Channel NewsAsia / Posted 18 days ago
would we be better off spending those resources into looking at more novel drugs?" Pazdur told Reuters during the annual American Society of Clinical Oncology (ASCO) meeting in Chicago this week. Pazdur acknowledged that the success of a few... Read more
11 related stories
More

People in this news